Case studies of companies aligning US and EU strategies for high risk devices

Case Studies of Companies Aligning US and EU Strategies for High Risk Devices In today’s globalized medical device market, regulatory compliance is not just a matter of adhering to local regulations; it’s also about aligning with international expectations to facilitate market entry and ensure patient safety. This article provides a comprehensive overview of global harmonization efforts, focusing on how medical device companies can align their US Food and Drug Administration (FDA) strategies with European Union (EU) directives such as the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The discussion includes an examination of the Medical Device Single…

Continue Reading... Case studies of companies aligning US and EU strategies for high risk devices

Interplay between US FDA device rules and EU MDR technical file requirements

Understanding the Interplay between US FDA Device Rules and EU MDR Technical File Requirements The regulatory landscape for medical devices is complex, particularly through the lens of global harmonization efforts such as the Medical Device Single Audit Program (MDSAP) and the European Union’s Medical Device Regulation (EU MDR). This tutorial aims to provide a comprehensive step-by-step guide for regulatory affairs, quality assurance, and clinical professionals navigating the intersection of US FDA device rules and EU MDR technical file prerequisites. As the market for medical devices continues to grow, harmonization within the regulatory frameworks is paramount for compliance and success in…

Continue Reading... Interplay between US FDA device rules and EU MDR technical file requirements

Using MDSAP audits to streamline global inspections for medical devices

Using MDSAP Audits to Streamline Global Inspections for Medical Devices In an increasingly interconnected global marketplace, regulatory compliance for medical devices presents one of the significant challenges for manufacturers. Various jurisdictions have their own requirements which can complicate the regulatory approval process, particularly in the context of the U.S. Food and Drug Administration (FDA) and the European Union (EU) regulations. The Medical Device Single Audit Program (MDSAP) allows organizations to undergo a single regulatory audit of their quality management system (QMS) that satisfies the requirements of multiple jurisdictions. This guide will explore how MDSAP audits can effectively streamline global inspections,…

Continue Reading... Using MDSAP audits to streamline global inspections for medical devices

Designing a single integrated QMS that satisfies FDA and EU device regulators

Designing a Single Integrated QMS that Satisfies FDA and EU Device Regulators In the highly regulated field of medical devices and combination products, establishing a Quality Management System (QMS) that complies with the requirements of multiple regulatory bodies can be daunting. This guide offers a step-by-step approach to create an integrated QMS that meets the expectations of both the U.S. Food and Drug Administration (FDA) and the European Union’s Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR). Emphasizing global harmonization, this tutorial will navigate the essential components of QMS design, including the global harmonization initiative, the Medical…

Continue Reading... Designing a single integrated QMS that satisfies FDA and EU device regulators

IVDR specific challenges for diagnostics firms also regulated by FDA

IVDR Specific Challenges for Diagnostics Firms Also Regulated by FDA With an increasing focus on global harmonization within the medical device industry, organizations are confronted with the complexities of navigating multiple regulatory frameworks. The In Vitro Diagnostic Regulation (IVDR) in the EU and the U.S. Federal Drug Administration (FDA) regulatory requirements pose significant challenges for diagnostics firms, especially those offering products across both markets. This article provides a comprehensive, step-by-step tutorial designed to help regulatory, quality, clinical, and RA/QA professionals understand and address these challenges effectively. Understanding the Regulatory Framework: IVDR and FDA Compliance The In Vitro Diagnostic Regulation (IVDR),…

Continue Reading... IVDR specific challenges for diagnostics firms also regulated by FDA

Using gap assessments to upgrade legacy systems for MDR and FDA alignment

Using Gap Assessments to Upgrade Legacy Systems for MDR and FDA Alignment In the increasingly complex regulatory landscape for medical devices and combination products, organizations must ensure that their legacy systems are adequately aligned with the requirements set forth by the FDA and the European Union’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). This article serves as a comprehensive guide for regulatory, quality, clinical, and RA/QA professionals on how to conduct gap assessments effectively to upgrade legacy systems for compliance with global harmonization MDSAP EU MDR IVDR FDA regulations. Understanding Gap Assessments in Regulatory Context Gap assessments…

Continue Reading... Using gap assessments to upgrade legacy systems for MDR and FDA alignment

Governance models for global regulatory teams covering US, EU, Canada and more

Governance Models for Global Regulatory Teams Covering US, EU, Canada and More As the landscape of medical device regulation continues to evolve, having a governance model that addresses global harmonization is essential for success in the regulatory framework. This guide provides a comprehensive overview of governance structures for global regulatory teams, with a focus on the interplay between the FDA and international regulations such as the EU MDR/IVDR and MDSAP (Medical Device Single Audit Program). In addition to detailing regulatory pathways, this tutorial will also discuss the necessity of an integrated Quality Management System (QMS), technical file requirements, and global…

Continue Reading... Governance models for global regulatory teams covering US, EU, Canada and more

Labeling, UDI and vigilance harmonisation for devices sold globally

Labeling, UDI and Vigilance Harmonisation for Devices Sold Globally In the rapidly evolving landscape of medical device regulation, achieving global harmonization remains a significant challenge for manufacturers and regulatory affairs professionals. With the advent of various regulatory frameworks such as the Medical Device Single Audit Program (MDSAP), the European Union Medical Device Regulation (EU MDR), and the In Vitro Diagnostic Regulation (IVDR), companies must navigate a complex world of compliance. This tutorial provides a step-by-step guide focused on aligning labeling, Unique Device Identification (UDI), and vigilance systems to fulfill the requirements set forth by the US FDA, while also considering…

Continue Reading... Labeling, UDI and vigilance harmonisation for devices sold globally

Managing differences in clinical evidence expectations across FDA and EU MDR

Managing differences in clinical evidence expectations across FDA and EU MDR Managing differences in clinical evidence expectations across FDA and EU MDR As the global marketplace for medical devices and combination products continues to evolve, understanding the distinct regulatory landscapes of the FDA in the United States and the European Union’s Medical Device Regulation (MDR) is crucial. This comprehensive tutorial is designed to guide professionals in navigating the complexities of global harmonization under the Medical Device Single Audit Program (MDSAP), EU MDR/IVDR, and the FDA’s requirements. We will explore key differences in clinical evidence expectations, the implications for clinical trial…

Continue Reading... Managing differences in clinical evidence expectations across FDA and EU MDR

Future trends in global device convergence and what they mean for QMS design

Future trends in global device convergence and what they mean for QMS design Future Trends in Global Device Convergence and What They Mean for QMS Design The rapid evolution of medical devices and combination products is leading to significant regulatory implications for companies engaged in these sectors. With the increasing convergence of devices, regulatory requirements are more interlinked than ever. Global harmonization initiatives, including the Medical Device Single Audit Program (MDSAP) and the European Union Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR), are crucial for ensuring compliance across different markets. This article provides a detailed, step-by-step…

Continue Reading... Future trends in global device convergence and what they mean for QMS design